Federal
Register Notices > Notices
of Registration - 2002 > Cerilliant
Corporation
[Federal Register: April 26, 2002 (Volume 67, Number
81)]
[Notices]
[Page 20826-20827]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26ap02-109]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Registration
By Notice dated November 16, 2001, and published in
the Federal Register on December 20, 2001, (66 FR 65744), Cerilliant
Corporation, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas
78708-0189, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed below:
Drug |
Schedule |
Cathinone (1235) |
I |
Methcathinone (1237) |
I |
N-Ethylamphetamine (1475) |
I |
N, N-Dimethylamphetamine (1480) |
I |
Aminorex (1585) |
I |
4-Methylaminorex (cis isomer)
(1590) |
I |
Gamma hydroxybutyric acid (2010) |
I |
Methaqualone (2565) |
I |
Alpha-Ethyltryptamine (7249) |
I |
Lysergic acid diethylamide (7315) |
I |
Tetrahydrocannabinols (7370) |
I |
Mescaline (7381) |
I |
3,4,5-Trimethoxyamphetamine
(7390) |
I |
4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
4-Methyl-2,5-dimethoxyamphetamine
(7395) |
|
2,5-Dimethoxyamphetamine (7396) |
I |
2,5-Dimethoxy-4-ethylamphetamine
(7399) |
I |
3,4-Methylenedioxyamphetamine
(7400) |
I |
5-Methoxy-3,4-methylenedioxyamphetamine
(7401) |
I |
N-Hydroxy-3,4-methylenedioxyamphetamine
(7402) |
I |
3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
3,4-Methylenedioxymethamphetamine
(7405) |
I |
4-Methoxyamphetamine (7411) |
I |
Bufotenine (7433) |
I |
Diethyltryptamine (7434) |
I |
Dimethyltryptamine (7435) |
I |
Psilocybin (7437) |
I |
Psilocyn (7438) |
I |
Acetyldihydrocodeine (9051) |
I |
Benzylmorphine (9052) |
I |
Codeine-N-oxide (9053) |
I |
Dihydromorphine (9145) |
I |
Heroin (9200) |
I |
Hydromorphinol (9301) |
I |
Methyldihydromorphine (9304) |
I |
Morphine-N-oxide (9307) |
I |
Normorphine (9313) |
I |
Pholcodine (9314) |
I |
Acetylmethadol (9601) |
I |
Allyprodine (9602) |
I |
Alphacetylmethadol except Levo |
I |
Alphacetylmethadol (9603) |
I |
Alphameprodine (9604) |
I |
Alphamethadol (9605) |
I |
Betacetylmethadol (9607) |
I |
Betameprodine (9608) |
I |
Betamethadol (9609) |
I |
Betaprodine (9611) |
I |
Hydromorphinol (9627) |
I |
Noracymethadol (9633) |
I |
Norlevorphanol (9634) |
I |
Normethadone (9635) |
I |
Trimeperidine (9646) |
I |
Phenomorphan (9647) |
I |
Para-Fluorofentanyl (9812) |
I |
3-Methylfentanyl (9813) |
I |
Alpha-methylfentanyl (9814) |
I |
Acetyl-alpha-methylfentanyl
(9815) |
I |
Beta-hydroxyfentanyl (9830) |
I |
Beta-hydroxy-3-methylfentanyl
(9831) |
I |
Alpha-Methylthiofentanyl (9832) |
I |
3-Methylthiofentanyl (9833) |
I |
Thiofentanyl (9835) |
I |
Amphetamine (1100) |
II |
Methamphetamine (1105) |
II |
Phenmetrazine (1631) |
II |
Methylphenidate (1724) |
II |
Amobarbital (2125) |
II |
Pentobarbital (2270) |
II |
Secobarbital (2315) |
II |
Glutehimide (2550) |
II |
Nabilone (7379) |
II |
1-Phenylcyclohexylamine (7460) |
II |
Phencyclidine (7471) |
II |
1-Piperidinocyclohexanecarbon-itrile
(8603) |
II |
Alphaprodine (9010) |
II |
Cocaine (9041) |
II |
Codeine (9050) |
II |
Dihydrocodeine (9120) |
II |
Oxycodone (9143) |
II |
Hydromorphone (9150) |
II |
Diphenoxylate (9170) |
II |
Benzoylecgonine (9180) |
II |
Ethylmorphine (9190) |
II |
Hydrocodone (9193) |
II |
Leveomthorphan (9210) |
II |
Levorphanol (9220) |
II |
Isomethadone (9226) |
II |
Meperidine (9230) |
II |
Methadone (9250) |
II |
Methadone-intermediate (9254) |
II |
Dextropropoxyphene, bulk
(non-dosage forms) (9273) |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Levo-alphacetylmethadol (9648) |
II |
Oxymorphone (9652) |
II |
[[Page 20827]]
Noroxymorphone (9668) |
II |
Racemethorphan (9732) |
II |
Alfentanil (9737) |
II |
Sufentanil (9740) |
II |
Fentanyl (9801) |
II |
The firm plans to manufacture small quantities of
the listed controlled substances to make deuterated and non-deuterated
drug reference standards which will be distributed to analytical and
forensic laboratories for drug testing programs.
No comments or objections have been received.
DEA has considered the factors in Title 21, United
Stated Code, Section 823(a) and determined that the registration of
Cerilliant Corporation to manufacture the listed controlled substances is
consistent with the public interest at this time. DEA has investigated
Cerilliant Corporation to ensure that the company's registration is
consistent with the public interest. This investigation included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and a
review of the company's background and history. Therefore, pursuant to 21
U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator,
Office of Diversion Control, hereby orders that the application submitted
by the above firm for registration as a bulk manufacturer of the basic
classes of controlled substances listed above is granted.
Dated: April 11, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 02-10300 Filed 4-25-02; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|